Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elie Rassy

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Therapeutic Advances in Medical Oncology|September 11, 2023
Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancerPauline Parent, Gautier Marcq, Sola Adeleke, et al.
Anticancer Research|February 29, 2024
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysisDaisy Eden, Aruni Ghose, Michele Moschetta, et al.
Cells|June 2, 2021
Targeting the VEGF Pathway in OsteosarcomaTarek Assi, Sarah Watson, Bachar Samra, et al.
Seminars in Oncology|March 24, 2020
TRK inhibition in soft tissue sarcomas: A comprehensive reviewTarek Assi, Elie Rassy, Hussein Nassereddine, et al.
Journal of the Egyptian National Cancer Institute|June 26, 2022
Sarcoma of unknown primary: myth or reality?Elie Rassy, Rosy Abou-Jaoude, Stergios Boussios, et al.
Cancer Treatment Reviews|June 17, 2024
Long road towards effective HER3 targeting in breast cancerFrancesca Papa, Thomas Grinda, Elie Rassy, et al.
Current Oncology Reports|October 7, 2020
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic LandscapesMarc El Beaino, Elie Rassy, Bana Hadid, et al.
Future Oncology (London, England)|June 8, 2021
Educational contribution of the College of the European School of Oncology to the Latin American OncologistsNicholas Pavlidis, Fedro A Peccatori, Alex Eniu, et al.
Cancer Treatment Reviews|May 2, 2026
Progress toward personalized management of stage II/III triple negative breast cancerIrene Valle, Joana M Ribeiro, Thomas Grinda, et al.
British Journal of Cancer|August 30, 2025
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physiciansElie Rassy, Suzette Delaloge, Yannis Slaouti, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|September 11, 2023
Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancerPauline Parent, Gautier Marcq, Sola Adeleke, et al.
Anticancer Research|February 29, 2024
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysisDaisy Eden, Aruni Ghose, Michele Moschetta, et al.
Cells|June 2, 2021
Targeting the VEGF Pathway in OsteosarcomaTarek Assi, Sarah Watson, Bachar Samra, et al.
Seminars in Oncology|March 24, 2020
TRK inhibition in soft tissue sarcomas: A comprehensive reviewTarek Assi, Elie Rassy, Hussein Nassereddine, et al.
Journal of the Egyptian National Cancer Institute|June 26, 2022
Sarcoma of unknown primary: myth or reality?Elie Rassy, Rosy Abou-Jaoude, Stergios Boussios, et al.
Cancer Treatment Reviews|June 17, 2024
Long road towards effective HER3 targeting in breast cancerFrancesca Papa, Thomas Grinda, Elie Rassy, et al.
Current Oncology Reports|October 7, 2020
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic LandscapesMarc El Beaino, Elie Rassy, Bana Hadid, et al.
Future Oncology (London, England)|June 8, 2021
Educational contribution of the College of the European School of Oncology to the Latin American OncologistsNicholas Pavlidis, Fedro A Peccatori, Alex Eniu, et al.
Cancer Treatment Reviews|May 2, 2026
Progress toward personalized management of stage II/III triple negative breast cancerIrene Valle, Joana M Ribeiro, Thomas Grinda, et al.
British Journal of Cancer|August 30, 2025
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physiciansElie Rassy, Suzette Delaloge, Yannis Slaouti, et al.
Pageof 10